Distribution and antifungal susceptibility testing of aspergillus species in patients with increased risk for invasive aspergillosis

被引：0
|
作者：
Mirchevska, G. [1 ]
Kotevska, V. [1 ]
Panovski, N. [1 ]
Popovska, K. [1 ]
Stojanoski, Z. [2 ]
Fustik-Naceva, S. [3 ]
Petrovska, M. [1 ]
Trajkovska-Dokic, E. [1 ]
机构：
[1] Med Fac, Inst Microbiol & Parasitol, Skopje, Macedonia
[2] Univ Sts Cyril & Methodius, Univ Clin Haematol, Skopje, Macedonia
[3] Univ Sts Cyril & Methodius, Univ Clin Pediat Dis, Skopje, Macedonia
来源：
MEDICAL MYCOLOGY | 2018年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P265
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Molecular identification and antifungal susceptibility patterns of invasive Aspergillus species following CLSI and EUCAST guidelines
    Dabas, Y.
    Xess, I.
    MEDICAL MYCOLOGY, 2018, 56 : S58 - S58
  • [32] Susceptibility testing in Aspergillus species complex
    Lass-Floerl, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 49 - 53
  • [33] Aspergillus fumigatus antigen detection in sera from patients at risk for invasive aspergillosis
    Chumpitazi, BFF
    Pinel, C
    Lebeau, B
    Ambroise-Thomas, P
    Grillot, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (01) : 438 - 443
  • [34] Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus
    Wetter, TJ
    Hazen, KC
    Cutler, JE
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (09) : 4252 - 4258
  • [35] Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis:: Difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy
    Lionakis, MS
    Lewis, RE
    Chamilos, G
    Kontoyiannis, DP
    PHARMACOTHERAPY, 2005, 25 (09): : 1174 - 1180
  • [36] Molecular epidemiology and antifungal susceptibility of Aspergillus species isolated from asthma patients
    Hedayati, M. T.
    Vakili, M.
    Mortezaei, V.
    Mahdaviani, S. A.
    Mirenayat, M. S.
    Pourabdollah, M.
    Heshmatnia, J.
    Fakharian, A.
    Pourdolat, G.
    Sharifynia, S.
    Alialy, M.
    Abastabar, M.
    Charati, J. Yazdani
    MEDICAL MYCOLOGY, 2018, 56 : S34 - S34
  • [37] Occurrence of Aspergillus species in hospitalized patients and azole antifungal susceptibility profile.
    Aneke, C. I.
    Cafarchia, C.
    Iatta, R.
    Otranto, D.
    MEDICAL MYCOLOGY, 2018, 56 : S84 - S84
  • [38] Antifungal susceptibility of the Aspergillus species by CLSI reference methods
    Altinbas, R.
    Ozakkas, F.
    Sav, H.
    Akkoyun, E.
    Turan, D.
    Baris, A.
    Kiraz, N.
    MYCOSES, 2015, 58 : 73 - 73
  • [39] Erratum to: Antifungal Susceptibility Profile of Cryptic Species of Aspergillus
    Ana Alastruey-Izquierdo
    Laura Alcazar-Fuoli
    Manuel Cuenca-Estrella
    Mycopathologia, 2015, 179 : 333 - 334
  • [40] Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis
    Miceli, Marisa H.
    Goggins, Michael I.
    Chander, Pranay
    Sekaran, Archana K.
    Kizy, Anne E.
    Samuel, Linoj
    Jiang, Hui
    Thornton, Christopher R.
    Ramesh, Mayur
    Alangaden, George
    MYCOSES, 2015, 58 (06) : 368 - 374
12345